Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : Donated US vaccines arrive for Mexican border cities

06/15/2021 | 10:37am EDT

MEXICO CITY (AP) — Mexico received 1.35 million doses of Johnson & Johnson coronavirus vaccines donated by the United States Tuesday and Mexican officials said that once they are applied, there would be no reason to continue restricting travel over the U.S. border.

The U.S. vaccine shipment will be used to vaccinate anyone over 18 in four cities along the U.S. border: Tijuana, Mexicali, Ciudad Juárez and Reynosa. Mexico has said the goal is to boost vaccination rates there to levels similar to the U.S. cities they adjoin.

Foreign Relations Secretary Marcelo Ebrard, who was meeting with U.S. Homeland Security Secretary Alejandro Mayorkas in Mexico City, said that after the vaccinations “there will be no public health arguments for keeping the border closed.”

The U.S. and Mexico have restricted border crossings to essential travel since early in the pandemic.

Assistant Health Secretary Hugo López-Gatell said the expanded vaccinations in border cities could begin Wednesday. Mexico is seeking to acquire more of the vaccine to inoculate all border residents.

Mexico has also donated 100,000 doses of AstraZeneca vaccine to Belize and 150,000 doses to Bolivia and Paraguay. Those vaccines were produced in Argentina and bottled at a plant in Mexico.

Mexico is running its own vaccination program using a mix of vaccines. That program is currently focusing on people over 40, and and has so far administered about 26 million shots, enough to cover about 30% of people in the country over 18.

Mexico had seen a fairly steady decline in coronavirus cases since an upsurge in December and January. However, this week the national reported case number rose by 8%, something López-Gatell attributed to a recent surge in cases in the state of Yucatan and the Caribbean coast state of Quintana Roo.

“There is a significant increase in case numbers” in those states and additional social-distancing measures are being implemented, he said.

The beach resorts of Quintana Roo are the country's main tourist attraction. An increase in cases has also been reported in Baja California Sur, home to the twin resorts of Los Cabos.

A popular domestic television reality competition show, “Guerreros,” announced Tuesday that it is suspending filming because some members of the cast or crew tested positive for COVID-19.

As the government's point man on the pandemic, López-Gatell had been criticized for casting doubt on the usefulness of face masks and for taking a beach vacation and walking in a public park at one point when he himself had been infected.

But López Obrador heaped praise on the assistant health secretary Tuesday, calling him "a model public servant."

López Obrador also returned to his old practice of comparing Mexico's coronavirus death rate to that of other countries, crowing about Mexico supposedly suffering fewer per-capita deaths than many other countries, including the United States, Brazil and Argentina.

However, López Obrador was using test-confirmed death numbers of about 230,000, which his own administration acknowledges is a vast undercount because the country does so little testing. Government reviews of death certificates suggest the real toll is now over 360,000.

The issue is a sensitive one, because Mexico's nearly three-month delay in bottling Argentine vaccines may have delayed vaccinations in the South American country and contributed to its elevated death rate.

The Mexican plant had trouble obtaining materials to complete the process, known as fill and finish.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

All news about JOHNSON & JOHNSON
06:06aJOHNSON & JOHNSON : 'Do Not Take J & J Vaccine If You Have Taken Astrazeneca' - ..
AQ
06:06aJOHNSON & JOHNSON : Investigation Opened Into Death of Woman After Receiving Cov..
AQ
06:06aJOHNSON & JOHNSON : SA Administers Over 255 000 Jabs, Records 7 773 New Covid-19..
AQ
07/27JOHNSON & JOHNSON : to Participate in the Virtual Wells Fargo Healthcare Confere..
PU
07/27JOHNSON & JOHNSON : Single-Shot COVID-19 Vaccinations to Resume in the U.S. for ..
AQ
07/27JOHNSON & JOHNSON : Mozambique to Vaccinate 20 Per Cent of Its Target By Septemb..
AQ
07/26ASPEN PHARMACARE : To Send First Batch Of Johnson & Johnson Jab To South Africa ..
MT
07/23Relaxed Border Restrictions For U.S. Travelers Coming August 9, 2021
AQ
07/23GLOBAL MARKETS LIVE : Intel, HoneyWell, American Express, Visa, Twitter...
07/23JOHNSON & JOHNSON : UBS Adjusts Johnson & Johnson's Price Target to $183 From $1..
MT
More news
Financials (USD)
Sales 2021 94 452 M - -
Net income 2021 22 808 M - -
Net cash 2021 471 M - -
P/E ratio 2021 20,3x
Yield 2021 2,40%
Capitalization 455 B 455 B -
EV / Sales 2021 4,81x
EV / Sales 2022 4,58x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 172,66 $
Average target price 184,35 $
Spread / Average Target 6,77%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON9.71%454 682
ROCHE HOLDING AG11.50%329 752
PFIZER, INC.14.37%235 663
NOVARTIS AG-0.44%221 987
ELI LILLY AND COMPANY44.27%221 420
ABBVIE INC.10.09%208 344